Category of Chemicals

CDK inhibitor

Cyclin-dependent kinase (CDK) inhibitors are a class of compounds designed to halt uncontrolled cell division, a hallmark of cancer. By blocking CDKs, these inhibitors disrupt the cell cycle, preventing cancer cells from proliferating. CDK inhibitors have shown promise in cancer therapy, with several approved for clinical use, offering new hope for patients by slowing down or even stopping the growth of tumors.

Products of CDK inhibitor
CAS No.	Product Name	Molecular Formula
1073485-20-7	3-[[6-(2-Methoxyphenyl)-4-pyrimidinyl]amino]benzenemethanesulfonamide	C₁₈H₁₈N₄O₃S
1169562-71-3	8-Chloro-2-(2S)-2-pyrrolidinylbenzofuro[3,2-d]pyrimidin-4(3H)-one hydrochloride (1:?)	C₁₄H₁₂ClN₃O₂.x(HCl)
1211441-98-3	LEE 011	C₂₃H₃₀N₈O
1231930-82-7	N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine methanesulfonate (1:1)	C₂₇H₃₂F₂N₈.CH₄O₃S
1285702-20-6	5-[4-[[(5-Methyl-2-furanyl)methyl]amino]-6-quinazolinyl]-2-furanmethanol	C₁₉H₁₇N₃O₃
131740-09-5	Flavopiridol hydrochloride	C₂₁H₂₀ClNO₅.HCl
1397219-81-6	BS 181 hydrochloride	C₂₂H₃₂N₆.HCl
186692-46-6	Roscovitine	C₁₉H₂₆N₆O
212844-53-6	Purvalanol A	C₁₉H₂₅ClN₆O
220036-08-8	NU6027	C₁₁H₁₇N₅O₂
300801-52-9	1-(3-Ethyl-5-methoxy-2(3H)-benzothiazolylidene)-2-propanone	C₁₃H₁₅NO₂S
345627-80-7	BMS-3870032	C₁₇H₂₄N₄O₂S₂
377090-84-1	SU 9516	C₁₃H₁₁N₃O₂
443797-96-4	4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide	C₁₅H₁₂F₂N₆O₃S
582315-72-8	(4-Butoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)(2,6-difluoro-4-methylphenyl)-methanone	C₁₈H₁₇F₂N₃O₂
602306-29-6	AZD 5438	C₁₈H₂₁N₅O₂S
718630-59-2	PHA-793887	C₁₉H₃₁N₅O₂
741713-40-6	Ro 4584820	C₁₈H₂₁F₂N₅O₄S
802539-81-7	PHA 848125	C₂₅H₃₂N₈O
827022-33-3	Palbociclib isethionate	C₂₄H₂₉N₇O₂.C₂H₆O₄S
844442-38-2	AT 7519	C₁₆H₁₇Cl₂N₅O₂
845714-00-3	CAY 10572	C₁₂H₁₁N₃O
872573-93-8	Ro 3306	C₁₈H₁₃N₃OS₂
920113-03-7	P276-00	C₂₁H₂₁Cl₂NO₅